Relating to school access.
Maryland bans step therapy for insulin and insulin-like drugs by insurers, HMOs, and PBMs; applies to new or renewed policies from Jan 1, 2026, speeding access for diabetics.
Maryland bans step therapy for insulin and insulin-like drugs by insurers, HMOs, and PBMs; applies to new or renewed policies from Jan 1, 2026, speeding access for diabetics.
WeVote — Public opinion
No community votes yet. Be the first to weigh in from the Vote tab.
Bill text & amendments
The official bill text and any amendments will be posted here once available.